CTKB Logo

Cytek Biosciences, Inc. (CTKB) 

NASDAQ
Market Cap
$877.85M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
629 of 966
Rank in Industry
75 of 120

Largest Insider Buys in Sector

CTKB Stock Price History Chart

CTKB Stock Performance

About Cytek Biosciences, Inc.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Insider Activity of Cytek Biosciences, Inc.

Over the last 12 months, insiders at Cytek Biosciences, Inc. have bought $0 and sold $617,404 worth of Cytek Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Cytek Biosciences, Inc. have bought $92.6M and sold $5.48M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 241,727 shares for transaction amount of $2.96M was made by RA CAPITAL MANAGEMENT, L.P. (director, 10 percent owner) on 2022‑03‑15.

List of Insider Buy and Sell Transactions, Cytek Biosciences, Inc.

2024-04-19SaleCHIEF TECHNOLOGY OFFICER
20,000
0.0152%
$5.87$117,400-3.21%
2024-04-09SaleCHIEF TECHNOLOGY OFFICER
1,900
0.0015%
$7.00$13,304-16.76%
2024-03-19SaleCHIEF TECHNOLOGY OFFICER
20,000
0.0153%
$6.71$134,200-11.49%
2024-03-18SaleCHIEF TECHNOLOGY OFFICER
20,000
0.0152%
$6.77$135,400-12.65%
2023-12-26SaleChief Financial Officer
3,000
0.0022%
$9.50$28,500-33.86%
2023-12-19SaleChief Technology Officer
20,000
0.0147%
$9.43$188,600-33.67%
2023-11-24SaleChief Financial Officer
3,000
0.0022%
$6.94$20,820-8.87%
2023-11-20SaleChief Technology Officer
20,000
0.0146%
$6.03$120,600+5.29%
2023-11-07SalePresident and CEO
20,000
0.0143%
$4.34$86,800+41.44%
2023-10-24SaleChief Financial Officer
3,000
0.0022%
$4.68$14,040+30.74%
2023-10-19SaleChief Technology Officer
20,000
0.0149%
$4.80$96,000+31.08%
2023-10-09SalePresident and CEO
20,000
0.0146%
$5.33$106,600+15.46%
2023-09-25SaleChief Financial Officer
3,000
0.0022%
$6.38$19,140-3.58%
2023-09-19SaleChief Technology Officer
20,000
0.0148%
$6.49$129,800-2.65%
2023-09-07SalePresident and CEO
20,000
0.0146%
$6.83$136,600-7.42%
2023-08-24SaleChief Financial Officer
3,000
0.0021%
$7.69$23,070-15.44%
2023-08-21SaleChief Technology Officer
20,000
0.0148%
$8.07$161,400-20.09%
2023-08-07SalePresident and CEO
20,000
0.0145%
$9.04$180,800-27.86%
2023-07-24SaleChief Financial Officer
3,000
0.0022%
$9.17$27,510-27.17%
2023-07-19SaleChief Technology Officer
20,000
0.0147%
$8.76$175,200-23.32%

Insider Historical Profitability

<0.0001%
Yan MingCHIEF TECHNOLOGY OFFICER
5988502
4.6491%
$6.82033
Jeanmonod PatrikChief Financial Officer
93400
0.0725%
$6.82020
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner
13381054
10.3881%
$6.82210<0.0001%
Shah Rajeev M.
13381054
10.3881%
$6.8230<0.0001%
Jiang WenbinPresident and CEO
5275796
4.0958%
$6.82023
Poirson AllenSVP Marketing and Corp. Dev.
40383
0.0314%
$6.8210
Dion Giseledirector
5000
0.0039%
$6.8210
Ball Jackdirector
3000
0.0023%
$6.8212
Barnett ValerieGeneral Counsel
1900
0.0015%
$6.8210

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$116.93M13.2817.43M-1.99%-$2.37M<0.01
Brown Capital Management$80.67M9.1612.02M+0.05%+$38,173.191.43
The Vanguard Group$80.61M9.1512.01M+1.03%+$819,324.54<0.01
RA Capital Management, L.P.$45.69M5.196.81M0%+$00.05
Hillhouse Capital Advisors Ltd$44.67M5.076.66M0%+$00.97
State Street$27.62M3.144.12M+2.95%+$792,383.90<0.01
New York State Common Retirement Fund$19.78M2.252.95M0%+$00.03
Geode Capital Management$16.83M1.912.51M+2.1%+$345,479.21<0.01
Dimensional Fund Advisors$9.23M1.051.38M+29.24%+$2.09M<0.01
Wellington Management Company$9.09M1.031.35M+4.93%+$427,507.53<0.01
Northern Trust$7.59M0.861.13M-5.04%-$402,613.39<0.01
Charles Schwab$6.05M0.69900,993+2.38%+$140,608.05<0.01
Morgan Stanley$5.66M0.64843,521+0.88%+$49,419.15<0.0001
BNY Mellon$5.2M0.59774,682-5.33%-$292,475.41<0.01
Connor Clark & Lunn Investment Management Ltd$4.24M0.48631,958+20.44%+$719,613.920.01
Fil Ltd$3.85M0.44573,6000%+$0<0.01
Goldman Sachs$3.78M0.43564,015+0.22%+$8,293.56<0.01
Fidelity Investments$3.51M0.4522,388<0.01%-$154.33<0.0001
Voloridge Investment Management, LLC$3.41M0.39507,592+2,035.52%+$3.25M0.01
Divisadero Street Capital Management Lp$3.27M0.37487,550New+$3.27M0.77
Invesco$2.36M0.27351,844+8.06%+$176,036.83<0.0001
RhumbLine Advisers$2.26M0.26337,312+2.96%+$64,965.60<0.01
Nuveen$2.05M0.23305,665-3.8%-$81,063.54<0.01
State of Wisconsin Investment Board$1.95M0.22290,808+3.68%+$69,220.370.01
Ameriprise Financial$1.94M0.22289,556-3.4%-$68,415.17<0.01
Legal & General$1.93M0.22287,666-0.38%-$7,381.00<0.0001
First Trust$1.64M0.19244,289New+$1.64M<0.01
Swiss National Bank$1.44M0.16214,000-6.35%-$97,295.00<0.01
Public Sector Pension Investment Board$1.38M0.16205,3370%+$00.01
American Century Investments$848,748.000.1126,490+162.97%+$525,990.25<0.01
Algert Global LLC$850,000.000.1126,610+12.78%+$96,339.150.03
Ubs Asset Management Americas Inc$832,919.000.1124,131+0.82%+$6,810.65<0.0001
Teachers Retirement System Of The State Of Kentucky$748,000.000.09111,363-4.77%-$37,439.290.01
Prudential Financial$753,077.000.09112,232-1.18%-$9,024.95<0.01
CalSTRS$736,100.000.08109,702-10.94%-$90,410.49<0.01
Barclays$715,000.000.08106,618-43.69%-$554,769.13<0.0001
AllianceBernstein$678,730.000.08101,152+0.64%+$4,321.24<0.0001
Alyeska Investment Group L P$671,000.000.08100,0000%+$0<0.01
Credit Suisse$627,331.000.0793,4920%+$0<0.01
Bank of America$599,651.000.0789,367+155.3%+$364,768.07<0.0001
Permanent School Fund$581,093.000.0786,601+2%+$11,420.430.01
Thrivent Financial For Lutherans$576,000.000.0785,842-2.64%-$15,627.59<0.01
JPMorgan Chase$573,114.000.0785,412-42.13%-$417,254.26<0.0001
Sherbrooke Park Advisers Llc$575,946.000.0785,834New+$575,946.000.11
UBS$556,307.000.0682,907+376,750%+$556,159.38<0.0001
Marshall Wace$460,245.000.0568,591New+$460,245.00<0.0001
Deutsche Bank$450,616.000.0567,156+2.37%+$10,413.90<0.0001
Janus Henderson$438,358.000.0565,474+0.02%+$73.65<0.0001
American International Group$431,594.000.0564,321-0.88%-$3,824.70<0.01
Citigroup$430,305.000.0564,129+5.04%+$20,633.22<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.